The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape
Background: Biopharmaceutical medicines represent a growing share of the global pharmaceutical market, and with many of these biopharmaceutical products facing loss of exclusivity rights, also biosimilars may now enter the biopharmaceutical market.Objectives: This study aims to identify and document...
Main Authors: | Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys, Paul Declerck, Arnold G. Vulto, Steven Simoens |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00314/full |
Similar Items
-
Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
by: Evelien Moorkens, et al.
Published: (2020-01-01) -
Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices
by: Liese Barbier, et al.
Published: (2021-05-01) -
Biosimilars in rheumatology and other fields of medicine
by: Marcin Milchert, et al.
Published: (2014-07-01) -
Biosimilars: Company Strategies to Capture Value from the Biologics Market
by: Juan Leonardo Martínez-Hurtado, et al.
Published: (2012-12-01) -
Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
by: Othman Montacir, et al.
Published: (2018-01-01)